4. Carbohydrate Metabolism

Learning Objectives

• Trace the ten steps of glycolysis and identify the three regulated, irreversible steps
• Explain how gluconeogenesis bypasses the irreversible steps of glycolysis using four unique enzymes
• Describe how glycogen synthesis and breakdown are hormonally regulated in liver and muscle
• Explain the two phases of the pentose phosphate pathway and what each phase produces
• Connect defects in these pathways to specific diseases: glycogen storage diseases, lactic acidosis, and G6PD deficiency
• Apply hormonal control (insulin vs. glucagon) to predict which pathway dominates in the fed versus fasted state

Quick Answer

Carbohydrate metabolism is the set of pathways that cells use to extract energy from glucose and to make glucose when none is available in the diet. Glycolysis breaks glucose down to pyruvate in the cytosol, generating a small amount of ATP and NADH and feeding the TCA cycle for full oxidation. When glucose is scarce, gluconeogenesis rebuilds it from lactate, glycerol, and amino acids, mostly in the liver. Glycogen acts as a short-term glucose buffer that is built up after meals and torn down between meals. The pentose phosphate pathway diverts glucose-6-phosphate toward NADPH and ribose-5-phosphate instead of ATP. Together these pathways keep blood glucose stable and are the biochemical explanation behind diabetes, lactic acidosis, and the inherited glycogen storage diseases that appear repeatedly on exams.

Glycolysis

Glycolysis is the universal starting point for glucose metabolism. It happens in the cytosol of every cell (even red blood cells, which have no mitochondria) and converts one 6-carbon glucose molecule into two 3-carbon pyruvate molecules. Because it doesn't need oxygen, glycolysis is the only ATP-generating pathway available to tissues under anaerobic conditions, such as exercising skeletal muscle or the renal medulla.

The Ten Steps

Glycolysis has an energy investment phase (steps 1-5, uses 2 ATP) and an energy payoff phase (steps 6-10, produces 4 ATP and 2 NADH), for a net gain of 2 ATP and 2 NADH per glucose.

1. Glucose → Glucose-6-phosphate (hexokinase/glucokinase, uses ATP) — traps glucose inside the cell since phosphorylated sugars can't cross the membrane
2. Glucose-6-phosphate → Fructose-6-phosphate (phosphoglucose isomerase)
3. Fructose-6-phosphate → Fructose-1,6-bisphosphate (phosphofructokinase-1, uses ATP) — the committed, rate-limiting step
4. Fructose-1,6-bisphosphate → DHAP + Glyceraldehyde-3-phosphate (aldolase) — splits the 6-carbon sugar into two 3-carbon pieces
5. DHAP → Glyceraldehyde-3-phosphate (triose phosphate isomerase) — so both halves continue down the same path
6. Glyceraldehyde-3-phosphate → 1,3-bisphosphoglycerate (GAPDH, produces NADH)
7. 1,3-bisphosphoglycerate → 3-phosphoglycerate (phosphoglycerate kinase, produces ATP — substrate-level phosphorylation)
8. 3-phosphoglycerate → 2-phosphoglycerate (phosphoglycerate mutase)
9. 2-phosphoglycerate → Phosphoenolpyruvate (enolase, releases water)
10. Phosphoenolpyruvate → Pyruvate (pyruvate kinase, produces ATP) — the second irreversible, substrate-level phosphorylation step

Because steps 6-10 happen twice per original glucose molecule, the payoff phase generates 4 ATP and 2 NADH total, minus the 2 ATP spent early on, for a net of 2 ATP and 2 NADH per glucose.

Regulation of Glycolysis

Three enzymes catalyze irreversible reactions and are the control points:

• Hexokinase/glucokinase — hexokinase (most tissues) is inhibited by its own product, glucose-6-phosphate; glucokinase (liver, pancreatic beta cells) has a much higher Km and is not product-inhibited, so it keeps working even when glucose is high — this lets the liver keep absorbing glucose after a meal
• Phosphofructokinase-1 (PFK-1) — the true rate-limiting, committed step. Activated by AMP and fructose-2,6-bisphosphate (a signal that insulin is high); inhibited by ATP and citrate (signals that energy is already abundant)
• Pyruvate kinase — activated by fructose-1,6-bisphosphate (feed-forward activation); inhibited by ATP and alanine

What Happens to Pyruvate

Pyruvate's fate depends on oxygen availability. With oxygen, pyruvate dehydrogenase converts it to acetyl-CoA, which enters the TCA cycle for complete oxidation to CO2, yielding roughly 30-32 ATP total per glucose through oxidative phosphorylation. Without enough oxygen, lactate dehydrogenase converts pyruvate to lactate, regenerating NAD+ so glycolysis can keep running — this is why intense exercise and hypoxic tissue produce lactic acid.

Gluconeogenesis

Gluconeogenesis makes new glucose from non-carbohydrate precursors — lactate, glycerol, and glucogenic amino acids — mainly in the liver and to a lesser extent the kidney. It runs during fasting, prolonged exercise, and starvation to keep the brain and red blood cells supplied with glucose, since they depend on it almost exclusively.

Gluconeogenesis is essentially glycolysis run in reverse, but three of glycolysis's steps are irreversible and must be bypassed using four dedicated enzymes:

Key Bypass Enzymes

1. Pyruvate carboxylase (mitochondria, biotin-dependent) — converts pyruvate to oxaloacetate; activated by acetyl-CoA, which signals that the TCA cycle is already saturated and carbon should be diverted to glucose
2. PEP carboxykinase (PEPCK) — converts oxaloacetate to phosphoenolpyruvate, releasing CO2
3. Fructose-1,6-bisphosphatase — converts fructose-1,6-bisphosphate back to fructose-6-phosphate; this is the main regulated step, inhibited by AMP and fructose-2,6-bisphosphate (mirroring PFK-1's activators in glycolysis, so the two pathways are never both fully active at once)
4. Glucose-6-phosphatase — the final step, converts glucose-6-phosphate to free glucose so it can leave the cell. Only liver, kidney, and intestine have this enzyme, which is why only these organs can release glucose into the blood — muscle can break down its own glycogen but cannot export the glucose

Regulation of Gluconeogenesis

• Hormonal control: Glucagon (fasting) raises cAMP and lowers fructose-2,6-bisphosphate, which turns off PFK-1 and turns on fructose-1,6-bisphosphatase — pushing flux toward glucose production. Insulin (fed state) does the opposite.
• Substrate availability: More lactate (from muscle), glycerol (from lipolysis), and amino acids (from muscle breakdown during fasting) drives more gluconeogenesis.
• Reciprocal regulation with glycolysis: The two pathways share several enzymes' substrates and are regulated as opposites so the cell never wastes energy running both simultaneously (a "futile cycle").

Glycogen Synthesis and Breakdown

Glycogen is the storage form of glucose, built as a large, highly branched polymer mainly in liver and skeletal muscle. Liver glycogen buffers blood glucose for the whole body; muscle glycogen is used locally to fuel contraction and cannot be released into the bloodstream because muscle lacks glucose-6-phosphatase.

Glycogen Synthesis (Glycogenesis)

1. Glucose is trapped as glucose-6-phosphate, then converted to glucose-1-phosphate
2. UDP-glucose pyrophosphorylase activates glucose as UDP-glucose, the actual donor molecule
3. Glycogen synthase — the rate-limiting enzyme — adds glucose units via alpha-1,4 glycosidic bonds to the growing chain
4. Branching enzyme creates alpha-1,6 branch points roughly every 8-10 residues, increasing solubility and the number of ends available for rapid simultaneous breakdown

Glycogen synthase is activated by insulin (via dephosphorylation) and by glucose-6-phosphate itself.

Glycogen Breakdown (Glycogenolysis)

1. Glycogen phosphorylase — the rate-limiting enzyme — cleaves alpha-1,4 bonds, releasing glucose-1-phosphate one unit at a time from the branch ends
2. Debranching enzyme removes the alpha-1,6 branch points so phosphorylase can continue
3. Glucose-1-phosphate is converted to glucose-6-phosphate, which either enters glycolysis (muscle) or is dephosphorylated by glucose-6-phosphatase and released as free glucose (liver)

Glycogen phosphorylase is activated by glucagon and epinephrine (via phosphorylation, cAMP-PKA cascade) and by AMP in muscle (signaling low energy during exercise); it is inhibited by ATP and glucose.

Glycogen Storage Diseases

Defects in these enzymes cause a family of inherited disorders, several of which are classic exam topics:

• Type I (von Gierke disease) — glucose-6-phosphatase deficiency — severe fasting hypoglycemia, lactic acidosis, hepatomegaly
• Type II (Pompe disease) — lysosomal alpha-glucosidase deficiency — cardiomegaly and muscle weakness (a lysosomal storage disease, not a cytosolic pathway defect)
• Type III (Cori disease) — debranching enzyme deficiency — milder hypoglycemia, glycogen with abnormally short outer branches
• Type V (McArdle disease) — muscle glycogen phosphorylase deficiency — exercise intolerance, muscle cramps, no rise in lactate with exercise

Pentose Phosphate Pathway

The pentose phosphate pathway (PPP, also called the hexose monophosphate shunt) runs alongside glycolysis in the cytosol but serves a completely different purpose: instead of generating ATP, it generates reducing power and biosynthetic precursors. It is especially active in tissues that do a lot of fatty acid synthesis (liver, adipose, lactating mammary gland) or that need protection from oxidative stress (red blood cells).

Oxidative Phase (irreversible)

1. Glucose-6-phosphate dehydrogenase (G6PD) — the rate-limiting, committed step — oxidizes glucose-6-phosphate and generates the first NADPH
2. 6-phosphogluconolactone is hydrolyzed, then 6-phosphogluconate dehydrogenase generates a second NADPH while releasing CO2 and producing ribulose-5-phosphate

This phase produces 2 NADPH per glucose-6-phosphate and is essentially irreversible.

Non-Oxidative Phase (reversible)

Ribulose-5-phosphate is converted to ribose-5-phosphate (for nucleotide synthesis) or shuffled by transketolase (thiamine/B1-dependent, transfers 2-carbon units) and transaldolase (transfers 3-carbon units) into glycolytic intermediates (fructose-6-phosphate and glyceraldehyde-3-phosphate) if the cell needs more ATP-generating capacity instead of ribose.

Why the Pentose Phosphate Pathway Matters

• NADPH is required for reductive biosynthesis (fatty acid and cholesterol synthesis) and for regenerating reduced glutathione, which neutralizes hydrogen peroxide and protects cells — especially red blood cells — from oxidative damage
• Ribose-5-phosphate supplies the sugar backbone for ATP, NADH, FAD, CoA, and DNA/RNA nucleotides
• G6PD deficiency, the most common human enzyme deficiency worldwide, leaves red blood cells unable to generate enough NADPH, making them vulnerable to oxidative stress from infections, fava beans, or oxidant drugs (e.g., primaquine, sulfonamides) — the result is hemolytic anemia with Heinz bodies and bite cells on blood smear

Concept Flow: Carbohydrate Metabolism Overview

Clinical Relevance of Carbohydrate Metabolism

• Diabetes mellitus — insulin deficiency or resistance leaves glucokinase and glycogen synthase under-activated and gluconeogenesis/glycogenolysis unopposed, producing chronic hyperglycemia
• Lactic acidosis — occurs when pyruvate cannot be oxidized fast enough (tissue hypoxia, pyruvate dehydrogenase deficiency, metformin toxicity), forcing excess pyruvate into lactate
• Fructose and galactose disorders — hereditary fructose intolerance (aldolase B deficiency) and classic galactosemia (GALT deficiency) both cause hypoglycemia and organ damage from accumulated toxic intermediates when the affected sugar is ingested
• Glycogen storage diseases — von Gierke, Pompe, Cori, and McArdle diseases each map to a single missing enzyme in the synthesis or breakdown pathways above
• G6PD deficiency — the pentose phosphate pathway's clinical face, causing drug- and infection-triggered hemolytic anemia

Key Terms

Term	Definition	Related Concept
Glycolysis	Ten-step cytosolic pathway converting one glucose to two pyruvate, net 2 ATP and 2 NADH	PFK-1, pyruvate kinase, anaerobic metabolism
Gluconeogenesis	Synthesis of new glucose from lactate, glycerol, or amino acids, mainly in liver	Pyruvate carboxylase, PEPCK, fasting state
Glycogenesis	Synthesis of glycogen from glucose for short-term storage	Glycogen synthase, UDP-glucose
Glycogenolysis	Breakdown of glycogen to release glucose-1-phosphate	Glycogen phosphorylase, debranching enzyme
Pentose Phosphate Pathway	Cytosolic pathway generating NADPH and ribose-5-phosphate instead of ATP	G6PD, oxidative phase, transketolase
Substrate-level phosphorylation	Direct transfer of a phosphate group to ADP to form ATP without the electron transport chain	Phosphoglycerate kinase, pyruvate kinase steps
Cori cycle	Lactate produced by muscle travels to the liver, where it is converted back to glucose	Gluconeogenesis, exercise physiology
Rate-limiting enzyme	The slowest, most tightly regulated step that sets the overall pace of a pathway	PFK-1 (glycolysis), glycogen synthase (glycogenesis)
Futile cycle	Simultaneous operation of opposing pathways that would waste ATP; prevented by reciprocal regulation	Glycolysis vs. gluconeogenesis
NADPH	Reduced coenzyme used for reductive biosynthesis and antioxidant defense, not for ATP production	Pentose phosphate pathway, glutathione
Glycogen storage disease	Inherited enzyme deficiency in glycogen metabolism causing organ-specific glucose/glycogen abnormalities	von Gierke, Pompe, Cori, McArdle disease
Committed step	The first irreversible reaction unique to a pathway, usually the main regulatory control point	PFK-1 in glycolysis, G6PD in the PPP

Common Mistakes

Misconception: Gluconeogenesis is simply glycolysis running backward through the exact same enzymes. Why it's wrong: Three glycolytic steps (hexokinase, PFK-1, pyruvate kinase) are thermodynamically irreversible in the cell. Gluconeogenesis must bypass each one with a different enzyme (pyruvate carboxylase + PEPCK, fructose-1,6-bisphosphatase, glucose-6-phosphatase). Correct understanding: Seven of the ten steps are shared and reversible, but the three irreversible steps require four dedicated bypass enzymes — this is exactly why the two pathways can be independently regulated instead of running as one wasteful futile cycle.

---

Misconception: Muscle glycogen can be broken down and released into the blood to raise blood glucose, just like liver glycogen. Why it's wrong: Muscle lacks glucose-6-phosphatase, the enzyme needed to remove the phosphate group so glucose can cross the cell membrane. Muscle glycogen can therefore only be used locally, within the muscle cell itself. Correct understanding: Only the liver (and to a lesser degree kidney and intestine) can export free glucose into the bloodstream, which is exactly why liver glycogen — not muscle glycogen — maintains fasting blood glucose.

---

Misconception: The pentose phosphate pathway is just "another way to make ATP" from glucose. Why it's wrong: The PPP produces NADPH, not ATP or NADH usable by the electron transport chain in the same way. Its purpose is reductive biosynthesis and antioxidant defense, not energy capture. Correct understanding: Tissues with high demand for fatty acid synthesis (liver, adipose) or antioxidant protection (red blood cells) rely heavily on the PPP for NADPH; tissues that mainly need ATP rely on glycolysis and oxidative phosphorylation instead.

Comparison and Connections

Feature	Glycolysis	Gluconeogenesis
Direction	Glucose → pyruvate	Pyruvate/lactate/amino acids → glucose
Location	Cytosol, all cells	Mainly liver (some kidney); cytosol + mitochondria
Net energy	Produces 2 ATP, 2 NADH	Consumes ~6 ATP equivalents
Key regulated enzyme	PFK-1 (activated by AMP, F2,6BP)	Fructose-1,6-bisphosphatase (inhibited by AMP, F2,6BP)
Dominant hormone	Insulin (fed state)	Glucagon (fasting state)
Clinical failure	Pyruvate kinase deficiency (hemolytic anemia)	Fasting hypoglycemia (PEPCK, F1,6BPase deficiency)

Feature	Glycogenesis	Glycogenolysis
Direction	Glucose → glycogen	Glycogen → glucose-1-phosphate
Key enzyme	Glycogen synthase	Glycogen phosphorylase
Activating hormone	Insulin	Glucagon, epinephrine
Tissue with systemic effect	Liver (buffers blood glucose)	Liver (raises blood glucose); muscle (local fuel only)

Practice Questions

Recall

1. Name the three irreversible, regulated steps of glycolysis and their enzymes. Answer guidance: Step 1, glucose → glucose-6-phosphate (hexokinase/glucokinase); step 3, fructose-6-phosphate → fructose-1,6-bisphosphate (PFK-1, the committed step); step 10, phosphoenolpyruvate → pyruvate (pyruvate kinase).

2. What are the four bypass enzymes unique to gluconeogenesis? Answer guidance: Pyruvate carboxylase, PEP carboxykinase, fructose-1,6-bisphosphatase, and glucose-6-phosphatase.

Understanding

3. Explain why the liver has glucokinase instead of hexokinase. Answer guidance: Glucokinase has a high Km (low affinity) and is not inhibited by glucose-6-phosphate, so it keeps phosphorylating glucose even at high blood glucose concentrations after a meal, allowing the liver to act as a glucose buffer. Hexokinase's product inhibition and low Km make it better suited to tissues that need first priority access to glucose at low concentrations.

4. Why must glycolysis and gluconeogenesis be reciprocally regulated rather than both running at full speed simultaneously? Answer guidance: If both pathways ran fully at once, the cell would burn ATP breaking down and rebuilding glucose in a "futile cycle" with no net benefit. Fructose-2,6-bisphosphate is the key reciprocal signal — high levels (fed state) activate PFK-1 and inhibit fructose-1,6-bisphosphatase, and low levels (fasting) do the opposite.

Application

5. A marathon runner's muscles feel fatigued and sore, with blood lactate rising sharply. Explain the biochemical basis using the Cori cycle. Answer guidance: During intense exercise, oxygen delivery cannot keep pace with ATP demand, so muscle relies on anaerobic glycolysis, converting pyruvate to lactate via lactate dehydrogenase to regenerate NAD+. This lactate travels through the blood to the liver, where gluconeogenesis converts it back to glucose (the Cori cycle), which can return to the muscle — an energy-shuttling relationship between the two organs.

6. An infant presents with severe fasting hypoglycemia, hepatomegaly, and lactic acidosis. Which enzyme deficiency is most likely, and why does fasting trigger symptoms? Answer guidance: Von Gierke disease (glucose-6-phosphatase deficiency, GSD type I). Without this enzyme, the liver cannot convert glucose-6-phosphate — from either glycogenolysis or gluconeogenesis — into free glucose to release into blood, so both pathways fail to raise blood glucose during fasting, and glucose-6-phosphate is shunted into lactate production instead.

Analysis

7. Compare what happens to pyruvate in a well-oxygenated cardiac myocyte versus a sprinting skeletal muscle cell, and explain the enzymatic basis for the difference. Answer guidance: In the oxygen-rich cardiac myocyte, pyruvate dehydrogenase converts pyruvate to acetyl-CoA for complete oxidation in the TCA cycle, yielding far more ATP. In the sprinting muscle cell, oxygen delivery cannot match demand, so lactate dehydrogenase reduces pyruvate to lactate, regenerating NAD+ so glycolysis (which requires continuous NAD+ for the GAPDH step) can continue producing ATP anaerobically. The difference is oxygen availability, not a difference in glycolysis itself.

8. A patient taking primaquine for malaria prophylaxis develops sudden hemolytic anemia. Explain the connection to the pentose phosphate pathway and predict what a peripheral blood smear would show. Answer guidance: The patient likely has G6PD deficiency. Reduced G6PD activity means less NADPH is generated, so red blood cells cannot regenerate reduced glutathione fast enough to neutralize oxidative stress from the oxidant drug. Hemoglobin becomes denatured and precipitates as Heinz bodies; splenic macrophages then remove the damaged portion of the membrane, producing bite cells on the smear.

FAQ

1. Do I need to memorize every single glycolysis enzyme by number? Know the ten steps in order well enough to identify the three irreversible ones (hexokinase/glucokinase, PFK-1, pyruvate kinase) and the two ATP-generating substrate-level phosphorylation steps (phosphoglycerate kinase, pyruvate kinase). Exam questions usually test the regulated steps and their disease associations, not the full sequence from memory.

2. Why does the body bother with gluconeogenesis instead of just storing enough glycogen? Liver glycogen only lasts about 12-24 hours of fasting. Gluconeogenesis is what keeps blood glucose stable during prolonged fasting, starvation, or intense exercise, using lactate, glycerol, and amino acids as raw material once glycogen stores run low.

3. What is the actual difference between glycogenesis and gluconeogenesis? The names look similar. Glycogenesis builds glycogen (a glucose polymer) from existing glucose for short-term storage in liver and muscle. Gluconeogenesis builds new glucose molecules from non-carbohydrate precursors like lactate and amino acids. One stores glucose you already have; the other manufactures glucose from scratch.

4. Why is fructose-2,6-bisphosphate not part of the glycolysis or gluconeogenesis pathway itself but still so important? It is a regulatory molecule, not a pathway intermediate. Its levels rise when insulin is high (fed state) and fall when glucagon is high (fasting), and it directly controls PFK-1 and fructose-1,6-bisphosphatase in opposite directions. It is the single biggest lever the body uses to decide whether glucose should be broken down or built up.

5. Is the pentose phosphate pathway tested as much as glycolysis on exams? Less extensively, but G6PD deficiency is a very high-yield clinical topic because it is common, X-linked, and has a classic trigger-and-presentation pattern (oxidant drugs or fava beans, Heinz bodies, bite cells). Know the oxidative phase and why NADPH matters even if you don't memorize every non-oxidative phase enzyme.

Quick Revision

• Glycolysis: glucose → 2 pyruvate, net 2 ATP + 2 NADH, cytosol, all cells; committed step is PFK-1
• Three irreversible glycolysis enzymes: hexokinase/glucokinase, PFK-1, pyruvate kinase
• Gluconeogenesis bypasses these three steps using pyruvate carboxylase, PEPCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase
• Only liver, kidney, and intestine have glucose-6-phosphatase and can release free glucose into blood
• Glycogen synthase builds glycogen (insulin-activated); glycogen phosphorylase breaks it down (glucagon/epinephrine-activated)
• Muscle glycogen fuels only the muscle cell itself; it cannot raise blood glucose
• Pentose phosphate pathway: oxidative phase makes 2 NADPH via G6PD (rate-limiting); non-oxidative phase makes ribose-5-phosphate
• G6PD deficiency causes oxidant-triggered hemolytic anemia with Heinz bodies and bite cells
• Glycogen storage diseases: von Gierke (G6Pase), Pompe (lysosomal acid alpha-glucosidase), Cori (debranching enzyme), McArdle (muscle phosphorylase)
• Fructose-2,6-bisphosphate reciprocally regulates PFK-1 and fructose-1,6-bisphosphatase to prevent a futile cycle
• Cori cycle: muscle lactate is shuttled to the liver and converted back to glucose via gluconeogenesis
• Excess anaerobic glycolysis, PDH deficiency, or metformin toxicity all raise lactate by limiting pyruvate oxidation

Related Topics

Prerequisites: Introduction to Biochemistry (enzyme catalysis, ATP, NAD+/NADH), basic cell biology (cytosol vs. mitochondria), the concept of hormonal signaling (insulin and glucagon)

Related Topics: TCA cycle and oxidative phosphorylation (where pyruvate's carbon is fully oxidized), lipid metabolism (glycerol and acetyl-CoA cross-talk with carbohydrate pathways), amino acid metabolism (glucogenic amino acids feed gluconeogenesis)

Next Topics: Protein Metabolism, Lipid Metabolism, Clinical Biochemistry and metabolic disease correlations, Endocrine regulation of metabolism (insulin and glucagon signaling in depth)

---

This page is for educational purposes. Always verify with current clinical guidelines.